From 10–12 December 2025, Czechia’s most prominent life-science institutions and biotech founders gathered in Luxembourg for the Czech Life Sciences & Biotech Showcase. As the event’s General Partner, IOCB Tech led the mission to bridge the gap between Central European innovation and Europe’s largest fund centre. Read more

IOCB Tech has announced the appointment of Dr Julie Proft as its new Deputy Director. Read more

Last week, the Prague.bio Conference 2025 successfully brought together an international community of scientists, investors, and biotech founders in a rare forum where all parties spoke the same language: the future of life sciences. Read more

A research team team led by Michal Tichy and supported by IOCB Tech presented its CDK9 inhibitor project to the MATWIN board during the oncology-focused MATWIN annual conference in Bordeaux, France. The MATWIN initiative, a key French open-innovation platform in oncology, brings together representatives from academia, major pharmaceutical companies, and clinical research institutions.   Read more

Czech research institutions presented several technological innovations with application potential in the fields of medicine and diagnostics at this year's BioVaria in Munich. IOCB Tech, in cooperation with the Institute of Organic Chemistry and Biochemistry of the CAS, i&i Prague, Prague.bio, the Institute of Physics of the CAS, the University of Chemistry and Technology in Prague, and the Faculty of Science of Charles University, actively showcased the results of Czech research at the traditional biotechnology conference within the Pitch & Partner and Investors' Forum sessions.   Read more

Companies affiliated with the IOCB Tech group showcased their know-how and services at the traditional spring gathering of the biotech industry - BIO-Europe Spring, held this year in Milan, Italy. With nearly 4,000 experts from the fields of pharmaceuticals, biotechnology, and investment, the event serves as a platform for establishing strategic partnerships and presenting Czech innovations. Read more

IOCB Tech is pleased to announce that Prof. Ing. Martin Fusek, CSc., has been appointed as a member of the Research, Development, and Innovation Council (RVVI) by the Office of the Government of the Czech Republic. This prestigious appointment reflects Prof. Fusek’s longstanding contributions to science and innovation, particularly in the field of technology transfer. Read more

Representatives from IOCB Tech Family will participate in a business mission accompanying the President of the Czech Republic, Petr Pavel, on his state visit to Switzerland from November 5 to 7, 2024. Organized by the Czech Chamber of Commerce, this delegation aims to strengthen both commercial and research relationships between the Czech Republic and Switzerland, particularly in the fields of biotechnology, pharmaceuticals, and innovation. Read more

Celebrating 30 years of fostering global partnerships in the life sciences, this year’s BIO-Europe conference has taken on a distinctly Swedish flavour with a special nod to ABBA. The iconic biotech gathering, nowadays held in Stockholm is not only a celebration of three decades of collaboration but also a showcase of innovation at the heart of the industry. The IOCB Tech Family, Prague.bio and other companies are proud to represent the Czech biotech sector at this landmark event, where ABBA-themed sessions are sparking creative discussions and new partnerships. Read more